Where is the live CopyMark page for USPTO serial 79029631?

The live record is at https://getcopymark.com/trademark/79029631. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns Serial No. 79029631?

According to the public USPTO record for serial number 79029631, the listed owner(s) include: Santhera Pharmaceuticals Holding AG, Santhera Pharmaceuticals Holding AG, Santhera Pharmaceuticals Holding AG.

What is USPTO serial number 79029631?

Serial number 79029631 is the USPTO application identifier for the mark Serial No. 79029631. It is used to track examination, publication, and registration of this trademark.

What is the current status of Serial No. 79029631?

Serial No. 79029631 (79029631) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover Serial No. 79029631?

The public record lists International Classes: 005, 009, 010, 016, 042, 044. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: Serial No. 79029631 Serial# 79029631 | status 404; last event DENC | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79029631?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patrick J. Concannon

Patrick J. Concannon Edwards Angell Palmer & Dodge LLPF.D.R. Station, P.O. Box 130New York, NY 10150UNITED STATES

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations for the treatment of central nervous system-related conditions, ophthalmological diseases and neuromuscular diseases; pharmaceutical preparations for the treatment of ataxia, muscular dystrophies, Lou Gehrig's disease, Parkinson, Huntington disease, spinal muscular atrophies, polyneurophaties, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; veterinary preparations for the treatment of central nervous system-related conditions, ophthalmological diseases and neuromuscular diseases; sanitary preparations for medical use; dietetic foods adapted for medical use	SECTION 71 - CANCELLED	—
009	Scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, computer hardware and software, for use with medical patient monitoring equipment, for measuring, receiving, processing, transmitting and displaying data; scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, computers, gamma cameras, collimators, aperture plates and computer software, all sold together as a unit for use in measuring the physical and mental condition of individuals affected by ataxia, muscular dystrophies, Lou Gehrig's disease, Parkinson, Huntington disease, spinal muscular atrophies, polyneurophaties, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; scientific, optical, weighing, measuring, signaling, monitoring, inspection, apparatus and instruments, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use	SECTION 71 - CANCELLED	—
010	Surgical and medical apparatus and instruments for use in general surgery	SECTION 71 - CANCELLED	—
016	Printed informational cards in the field of pharmaceuticals; printed publications, namely, newsletters, case studies, and white papers in the fields of pharmaceuticals, central nervous system-related conditions, ophthalmological diseases, and neuromuscular diseases	SECTION 71 - CANCELLED	—
042	Pharmaceutical research and development services; chemical analysis for the pharmaceutical industry; scientific research and development; scientific research, namely, conducting clinical trials; providing scientific research information in the field of pharmaceuticals and clinical trials	SECTION 71 - CANCELLED	—
044	Hygienic and beauty care for human beings or animals, namely, providing health, medical and pharmaceutical information, consultancy and advisory services	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Sep 28, 2018	DENC	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED	—
Sep 28, 2018	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Aug 21, 2015	INNT	TOTAL INVALIDATION PROCESSED BY THE IB	—
Aug 3, 2015	INTS	TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	—
Aug 3, 2015	INPC	INVALIDATION PROCESSED	—
May 12, 2015	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Sep 12, 2014	C71T	CANCELLED SECTION 71	—
Jul 18, 2011	ADCH	CHANGE OF NAME/ADDRESS REC'D FROM IB	—
Jul 2, 2010	CORV	REVIEW OF CORRESPONDENCE COMPLETE	—
Jul 2, 2010	APRE	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	—
May 19, 2010	ARAA	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 19, 2010	REAP	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	—
May 13, 2010	MAIL	PAPER RECEIVED	—
Jun 5, 2009	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
May 7, 2008	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
May 6, 2008	FIMP	FINAL DISPOSITION PROCESSED	—
May 5, 2008	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Feb 5, 2008	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 20, 2007	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 31, 2007	NPUB	NOTICE OF PUBLICATION	—
Oct 15, 2007	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Oct 15, 2007	ALIE	ASSIGNED TO LIE	—
Sep 13, 2007	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Aug 16, 2007	XAEC	EXAMINER'S AMENDMENT ENTERED	—
Aug 16, 2007	GNEN	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	—
Aug 16, 2007	GNEA	EXAMINERS AMENDMENT E-MAILED	—
Aug 16, 2007	CNEA	EXAMINERS AMENDMENT -WRITTEN	—
Jul 25, 2007	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Jul 24, 2007	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jul 24, 2007	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 9, 2007	GNFN	NOTIFICATION OF FINAL REFUSAL EMAILED	—
Jul 9, 2007	GNFR	FINAL REFUSAL E-MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 9, 2007	CNFR	FINAL REFUSAL WRITTEN	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 13, 2007	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Jun 13, 2007	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jun 13, 2007	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2007	ARAA	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2007	REAP	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	—
Mar 15, 2007	RFNT	REFUSAL PROCESSED BY IB	—
Feb 21, 2007	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Feb 21, 2007	RFRR	REFUSAL PROCESSED BY MPU	—
Feb 18, 2007	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Feb 17, 2007	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2007	DOCK	ASSIGNED TO EXAMINER	—
Nov 14, 2006	NWAP	NEW APPLICATION ENTERED	—
Nov 9, 2006	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

Serial No. 79029631